| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.694 | 21.880 | 33.175 | 52.675 | 61.855 | 79.643 | 100.781 | 125.795 | 144.462 |
| Total Income - EUR | - | 7.694 | 21.880 | 33.175 | 52.676 | 61.856 | 79.645 | 101.997 | 126.018 | 146.685 |
| Total Expenses - EUR | - | 1.407 | 3.451 | 1.576 | 17.164 | 13.603 | 36.406 | 90.794 | 111.790 | 134.886 |
| Gross Profit/Loss - EUR | - | 6.287 | 18.429 | 31.599 | 35.512 | 48.253 | 43.240 | 11.203 | 14.228 | 11.799 |
| Net Profit/Loss - EUR | - | 6.058 | 17.779 | 30.604 | 33.932 | 47.067 | 42.539 | 10.346 | 13.031 | 8.461 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Conta Next Infusion Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 18.332 | 13.249 | 114.977 | 81.669 | 48.301 |
| Current Assets | - | 6.344 | 24.090 | 54.637 | 87.679 | 114.524 | 161.909 | 140.417 | 145.470 | 199.910 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 35.312 | 35.421 | 81.478 | 170.242 |
| Receivables | - | 289 | 569 | 3.227 | 3.627 | 3.900 | 4.533 | 5.393 | 7.218 | 9.294 |
| Cash | - | 6.055 | 23.521 | 51.409 | 84.052 | 110.624 | 122.064 | 99.602 | 56.774 | 20.373 |
| Shareholders Funds | - | 6.102 | 23.778 | 53.946 | 86.833 | 132.254 | 171.860 | 182.740 | 195.217 | 202.587 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 242 | 312 | 690 | 846 | 602 | 3.298 | 72.654 | 31.922 | 45.623 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Conta Next Infusion Srl